{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:56:18Z","timestamp":1771674978765,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.annder.2018.07.023","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T18:46:56Z","timestamp":1538765216000},"page":"769-772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["\u0152d\u00e8me palp\u00e9bral induit par le pemetrexed (Alminta\u00ae)"],"prefix":"10.1016","volume":"145","author":[{"given":"A.","family":"Badaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2018.07.023_bib0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5732\/cjc.014.10151","article-title":"Toxic epidermal necrolysis related to AP (pemetrexed plus cisplatin) and gefitinib combination therapy in a patient with metastatic non-small cell lung cancer","volume":"34","author":"Huang","year":"2015","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.annder.2018.07.023_bib0160","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/1346-8138.13354","article-title":"Pemetrexed-induced scleroderma-like conditions in the lower legs of a patient with non-small cell lung carcinoma","volume":"43","author":"Ishikawa","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2018.07.023_bib0165","first-page":"473","article-title":"Inflamed actinic keratoses after pemetrexed","volume":"14","author":"Cameron","year":"2016","journal-title":"Skinmed"},{"key":"10.1016\/j.annder.2018.07.023_bib0170","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/DAD.0000000000000645","article-title":"Pemetrexed-induced pseudocellulitis reaction with eosinophilic infiltrate on skin biopsy","volume":"39","author":"Tracey","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.annder.2018.07.023_bib0175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.18433\/J32C8D","article-title":"Anaphylactic reaction to pemetrexed: a case report","volume":"17","author":"Capelle","year":"2014","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.annder.2018.07.023_bib0180","first-page":"1179","article-title":"Pemetrexed-induced radiation recall dermatitis of the breast","volume":"34","author":"Boesmans","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.annder.2018.07.023_bib0185","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.lungcan.2013.02.019","article-title":"Pemetrexed-induced neutropenic enteritis and severe cutaneous hyperpigmentation in a patient with malignant pleural mesothelioma","volume":"80","author":"Buchinger","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.annder.2018.07.023_bib0190","first-page":"769","article-title":"Revisiting cutaneous adverse reactions to pemetrexed","volume":"2","author":"Pi\u00e9rard-Franchimont","year":"2011","journal-title":"Oncol Lett"},{"key":"10.1016\/j.annder.2018.07.023_bib0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1078155215583523","article-title":"Single-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions","volume":"22","author":"Elsoueidi","year":"2016","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.annder.2018.07.023_bib0200","first-page":"5185","article-title":"Pemetrexed-induced eyelid edema: incidence and clinical manifestations","volume":"30","author":"Schallier","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.annder.2018.07.023_bib0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.lungcan.2010.04.024","article-title":"Pemetrexed-induced edema of the eyelid","volume":"69","author":"Guhl","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.annder.2018.07.023_bib0210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.lungcan.2006.08.002","article-title":"Pemetrexed-induced edema of the eyelid","volume":"54","author":"Kurata","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.annder.2018.07.023_bib0215","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1097\/SCS.0b013e318285d5c2","article-title":"Pemetrexed-induced eyelid edema in lung cancer","volume":"24","author":"Martins-Filho","year":"2013","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.annder.2018.07.023_bib0220","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1097\/JTO.0b013e3182333f34","article-title":"Peripheral skin edema as unusual toxicity in three patients with advanced non-small cell lung cancer treated with pemetrexed alone or in combination with cisplatin","volume":"6","author":"Galetta","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.annder.2018.07.023_bib0225","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4103\/0253-7613.194862","article-title":"Eyelid and feet edema induced by pemetrexed","volume":"48","author":"Kastalli","year":"2016","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.annder.2018.07.023_bib0230","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1097\/JTO.0b013e31822e722f","article-title":"Skin toxicities compromise prolonged pemetrexed treatment","volume":"6","author":"Eguia","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.annder.2018.07.023_bib0235","first-page":"844","article-title":"Diagnostic d\u2019un \u0153d\u00e8me orbito-palp\u00e9bral","volume":"126","author":"Scrivener","year":"1999","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.07.023_bib0240","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0151-9638(06)70922-X","article-title":"\u0152d\u00e8me p\u00e9riorbitaire bilat\u00e9ral","volume":"133","author":"Ksontini","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.07.023_bib0245","first-page":"655","article-title":"\u0152d\u00e8mes orbito-pal\u00e9braux","volume":"130","author":"Bont\u00e9","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.07.023_bib0250","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archopht.1993.01090080023010","article-title":"Proptosis and periorbital edema due to diltiazem treatment","volume":"111","author":"Friedland","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.annder.2018.07.023_bib0255","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.1998.16.10.3426","article-title":"Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment","volume":"16","author":"Semb","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annder.2018.07.023_bib0260","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0181-5512(04)96103-7","article-title":"\u0152d\u00e8me palp\u00e9bral secondaire au traitement par inhibiteur de la tyrosine kinase\u00a0: Glivec\u00ae. \u00c0 propos d\u2019une observation anatomoclinique","volume":"27","author":"Maalouf","year":"2004","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.annder.2018.07.023_bib0265","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2010.28.15_suppl.tps332","article-title":"Preliminary data of nilotinib in the first line treatment of patients with metastatic or unresectable gastrointestinal stromal tumors (GIST)","volume":"28","author":"Casali","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annder.2018.07.023_bib0270","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1097\/01.TP.0000162433.34739.61","article-title":"Clinical experience with everolimus (Certican): optimizing dose and tolerability","volume":"79","author":"Pascual","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.annder.2018.07.023_bib0275","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00007890-200107150-00031","article-title":"Sirolimus-associated eyelid edema in kidney transplant recipients","volume":"72","author":"Mohaupt","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.annder.2018.07.023_bib0280","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.TP.0000151630.25127.3A","article-title":"Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy","volume":"79","author":"Mah\u00e9","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.annder.2018.07.023_bib0285","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/01676830.2011.648818","article-title":"Bisphosphonate-associated orbital inflammation: a case report and review","volume":"31","author":"Peterson","year":"2012","journal-title":"Orbit"},{"key":"10.1016\/j.annder.2018.07.023_bib0290","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/JCP.0b013e31818ce380","volume":"28","author":"Pelizza","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.annder.2018.07.023_bib0295","doi-asserted-by":"crossref","first-page":"e1610","DOI":"10.1097\/MD.0000000000001610","article-title":"Nonallergic eyelid edema after botulinum toxin type A injection: case report and review of literature","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.annder.2018.07.023_bib0150","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1097\/IOP.0000000000000186","article-title":"Pemetrexed-associated eyelid edema: effective treatment by excision of lymphedematous eyelid tissue","volume":"31","author":"Carlson","year":"2015","journal-title":"Ophthal Plast Reconstr Surg"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818305246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818305246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:06:39Z","timestamp":1758971199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963818305246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0151963818305246"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2018.07.023","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u0152d\u00e8me palp\u00e9bral induit par le pemetrexed (Alminta\u00ae)","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2018.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}